biotinylated anti mouse lgg secondary antibody (Vector Laboratories)
Vector Laboratories is a verified supplier 
Vector Laboratories manufactures this product 
96
Structured Review
Vector Laboratories
biotinylated anti mouse lgg secondary antibody
Biotinylated Anti Mouse Lgg Secondary Antibody, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1837 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biotinylated+anti+mouse+lgg+secondary+antibody/Mouse+on+Mouse+(M%2EO%2EM%2E+)+Biotinylated+Anti-Mouse+Ig+Reagent/pm41386343-94-6-16
Average 96 stars, based on 1837 article reviews
Biotinylated Anti Mouse Lgg Secondary Antibody, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1837 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biotinylated+anti+mouse+lgg+secondary+antibody/Mouse+on+Mouse+(M%2EO%2EM%2E+)+Biotinylated+Anti-Mouse+Ig+Reagent/pm41386343-94-6-16
Average 96 stars, based on 1837 article reviews
biotinylated anti mouse lgg secondary antibody - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Incubation:Article Title: Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands with Disease-Modifying Effects on α-Synuclein Mouse Models of Parkinson’s Disease Article Snippet: Ig blocking reagent for 30 min. Further, the sections were incubated with M.O.M. diluent for 5 min and then transferred to mouse anti-human αSynO5 primary antibody (1:200 in M.O.M. diluent, AS132718, Agrisera) for overnight incubation. αSynO5 primary antibody is oligomer-specific and does not react with mouse endogenous αSyn in tissue IHC. .. The sections were then incubated with Article Title: Novel PREP ligand, HUP-46, ameliorates behavioral deficits in an alpha-synuclein based Parkinson's disease model. Article Snippet: Parkinson’s disease (PD) is the most common neurodegenerative movement disorder, and current therapies cannot stop or delay the neuronal death.. Therefore, novel therapies having disease-modifying effects are urgently needed.. Small-molecular ligands for prolyl oligopeptidase (PREP) have shown disease-modifying effects in various α-synuclein (aSyn) based PD mouse models. Article Title: Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model. Article Snippet: The sections were incubated overnight at room temperature with rabbit anti-TH primary antibody (1:2000 in 1% normal goat serum in 0.5% Triton-X in PBS, AB152, Sigma-Aldrich) or by mouse anti-human αSynO5 primary antibody (1:200 in M.O.M. diluent, AS132718, Agrisera). αSynO5 primary antibody is oligomer-specific (Brannstrom et al., 2014) and does not react with mouse endogenous αSyn in tissue IHC (Svarcbahs et al., 2016). .. After washes, the sections were incubated with biotinylated goat anti-rabbit secondary antibody (TH; 1:500 in 1% normal goat serum in 0.5% Triton-X in PBS, BA1000, Vector Laboratories) or by Avidin-Biotin Assay:Article Title: Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands with Disease-Modifying Effects on α-Synuclein Mouse Models of Parkinson’s Disease Article Snippet: Ig blocking reagent for 30 min. Further, the sections were incubated with M.O.M. diluent for 5 min and then transferred to mouse anti-human αSynO5 primary antibody (1:200 in M.O.M. diluent, AS132718, Agrisera) for overnight incubation. αSynO5 primary antibody is oligomer-specific and does not react with mouse endogenous αSyn in tissue IHC. .. The sections were then incubated with Article Title: Novel PREP ligand, HUP-46, ameliorates behavioral deficits in an alpha-synuclein based Parkinson's disease model. Article Snippet: Parkinson’s disease (PD) is the most common neurodegenerative movement disorder, and current therapies cannot stop or delay the neuronal death.. Therefore, novel therapies having disease-modifying effects are urgently needed.. Small-molecular ligands for prolyl oligopeptidase (PREP) have shown disease-modifying effects in various α-synuclein (aSyn) based PD mouse models. Article Title: Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model. Article Snippet: The sections were incubated overnight at room temperature with rabbit anti-TH primary antibody (1:2000 in 1% normal goat serum in 0.5% Triton-X in PBS, AB152, Sigma-Aldrich) or by mouse anti-human αSynO5 primary antibody (1:200 in M.O.M. diluent, AS132718, Agrisera). αSynO5 primary antibody is oligomer-specific (Brannstrom et al., 2014) and does not react with mouse endogenous αSyn in tissue IHC (Svarcbahs et al., 2016). .. After washes, the sections were incubated with biotinylated goat anti-rabbit secondary antibody (TH; 1:500 in 1% normal goat serum in 0.5% Triton-X in PBS, BA1000, Vector Laboratories) or by |